{"id":14354,"date":"2019-04-30T10:47:42","date_gmt":"2019-04-30T08:47:42","guid":{"rendered":"https:\/\/www.satt.fr\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/"},"modified":"2019-04-30T12:34:32","modified_gmt":"2019-04-30T10:34:32","slug":"la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/","title":{"rendered":"La SATT Ouest Valorisation entre dans le capital de GoLiver Therapeutics, spin-off nantaise pionni\u00e8re de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative du foie"},"content":{"rendered":"<p><span style=\"color: #271d67;\"><strong>D\u00e9p\u00f4t de brevets, programme de maturation, transfert technologique, accompagnement \u00e0 la cr\u00e9ation,<\/strong><\/span><br \/>\n<span style=\"color: #271d67;\"><strong>depuis l\u2019origine, la SATT Ouest Valorisation est associ\u00e9e au d\u00e9veloppement de GoLiver Therapeutics. Au<\/strong><\/span><br \/>\n<span style=\"color: #271d67;\"><strong>c\u0153ur des priorit\u00e9s de l\u2019i-site NExT Sant\u00e9 du Futur, ce premier investissement de la SATT dans le capital d\u2019une<\/strong><\/span><br \/>\n<span style=\"color: #271d67;\"><strong>start-up des Pays de la Loire confirme son soutien financier \u00e0 une biotech prometteuse.<\/p>\n<p><\/strong>Cr\u00e9\u00e9e en Avril 2017, GoLiver Therapeutics est une spin-off de l\u2019Inserm et de l\u2019Universit\u00e9 de Nantes (CRTI UMR1064,<\/span><br \/>\n<span style=\"color: #271d67;\">ITUN), sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de M\u00e9dicaments de Th\u00e9rapie Innovante (MTI) pour r\u00e9pondre \u00e0 un besoin<\/span><br \/>\n<span style=\"color: #271d67;\">m\u00e9dical urgent non satisfait en transplantation.<\/span><\/p>\n<p><span style=\"color: #271d67;\">Deux ans apr\u00e8s sa cr\u00e9ation, GoLiver Therapeutics est en phase d\u2019industrialisation de la fabrication de son premier<\/span><br \/>\n<span style=\"color: #271d67;\">candidat-m\u00e9dicament qui est une suspension injectable de cellules h\u00e9patiques allog\u00e9niques et congel\u00e9es. Elle se<\/span><br \/>\n<span style=\"color: #271d67;\">d\u00e9marque de ses concurrents par le potentiel de sa technologie de rupture et son proc\u00e9d\u00e9 de fabrication unique bas\u00e9 sur<\/span><br \/>\n<span style=\"color: #271d67;\">les cellules souches pluripotentes qui permettent de fabriquer in vitro tout type de cellules du corps.<\/span><\/p>\n<p><span style=\"color: #271d67;\">Elle a pour ambition de devenir un leader mondial majeur dans la m\u00e9decine r\u00e9g\u00e9n\u00e9rative en s\u2019appuyant sur la<\/span><br \/>\n<span style=\"color: #271d67;\">r\u00e9g\u00e9n\u00e9rescence h\u00e9patique pour traiter les insuffisances aigu\u00ebs et chroniques s\u00e9v\u00e8res du foie sans avoir recours \u00e0 une<\/span><br \/>\n<span style=\"color: #271d67;\">greffe d\u2019organes.<\/span><\/p>\n<p><strong><span style=\"color: #08aabb;\">Tuan Huy Nguyen, CEO, GoLiver Therapeutics<\/span><\/strong><br \/>\n<span style=\"color: #271d67;\">\u00ab L\u2019implication de la SATT Ouest Valorisation dans notre structure capitalistique s\u2019inscrit dans une d\u00e9marche<\/span><br \/>\n<span style=\"color: #271d67;\">d\u2019accompagnement de long terme. Elle t\u00e9moigne d\u2019une parfaite compr\u00e9hension de la strat\u00e9gie de d\u00e9veloppement d\u2019une<\/span><br \/>\n<span style=\"color: #271d67;\">soci\u00e9t\u00e9 de biotech comme la n\u00f4tre, en facilitant nos avanc\u00e9es dans ce moment cl\u00e9 qu\u2019est la phase d\u2019industrialisation de<\/span><br \/>\n<span style=\"color: #271d67;\">la fabrication d\u2019un produit de th\u00e9rapie cellulaire innovant en vue d\u2019essais cliniques.<\/span><br \/>\n<span style=\"color: #271d67;\">Cette entr\u00e9e de la SATT Ouest Valorisation dans notre capital repr\u00e9sente aussi un signal positif fort et un \u00e9l\u00e9ment<\/span><br \/>\n<span style=\"color: #271d67;\">rassurant pour de futurs investisseurs, et confirme le potentiel march\u00e9 r\u00e9sultant de la propri\u00e9t\u00e9 intellectuelle exploit\u00e9e et<\/span><br \/>\n<span style=\"color: #271d67;\">d\u00e9velopp\u00e9e par GoLiver Therapeutics. \u00bb.<\/span><\/p>\n<p>\n<strong><span style=\"color: #08aabb;\">Vincent Lamande, Pr\u00e9sident de la SATT Ouest Valorisation<\/span><\/strong><br \/>\n<span style=\"color: #271d67;\">\u00ab Pour la SATT, nous savions d\u00e8s le d\u00e9but du projet que notre accompagnement aupr\u00e8s de GoLiver Therapeutics pourrait<\/span><br \/>\n<span style=\"color: #271d67;\">aller jusqu\u2019\u00e0 la prise de parts \u00e0 son capital afin de soutenir son ambitieux d\u00e9veloppement sans ob\u00e9rer ses marges de<\/span><br \/>\n<span style=\"color: #271d67;\">manoeuvre financi\u00e8res. Je suis tr\u00e8s satisfait de voir GoLiver Therapeutics profiter de la large palette d\u2019outils \u00e0 disposition<\/span><br \/>\n<span style=\"color: #271d67;\">dont la SATT dispose, notamment la prise de participation au capital, nous permettant ainsi de conforter les lev\u00e9es de<\/span><br \/>\n<span style=\"color: #271d67;\">fonds et lui donner le maximum de chance de r\u00e9ussite. \u00bb.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>D\u00e9p\u00f4t de brevets, programme de maturation, transfert technologique, accompagnement \u00e0 la cr\u00e9ation, depuis l\u2019origine, la SATT Ouest Valorisation est associ\u00e9e au d\u00e9veloppement de GoLiver Therapeutics. Au c\u0153ur des priorit\u00e9s de l\u2019i-site NExT Sant\u00e9 du Futur, ce premier investissement de la SATT dans le capital d\u2019une start-up des Pays de la Loire confirme son soutien financier [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":14351,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567,562],"tags":[],"class_list":["post-14354","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-satt-network"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La SATT Ouest Valorisation entre dans le capital de GoLiver Therapeutics, spin-off nantaise pionni\u00e8re de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative du foie - R\u00e9seau SATT<\/title>\n<meta name=\"description\" content=\"Ce premier investissement de la SATT dans le capital d\u2019une start-up des Pays de la Loire confirme son soutien financier \u00e0 une biotech prometteuse.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anne Guedon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/\"},\"author\":{\"name\":\"Anne Guedon\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e\"},\"headline\":\"La SATT Ouest Valorisation entre dans le capital de GoLiver Therapeutics, spin-off nantaise pionni\u00e8re de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative du foie\",\"datePublished\":\"2019-04-30T08:47:42+00:00\",\"dateModified\":\"2019-04-30T10:34:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/\"},\"wordCount\":499,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/04\/GoLiver-T.png\",\"articleSection\":[\"News\",\"SATT Network\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/\",\"url\":\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/\",\"name\":\"La SATT Ouest Valorisation entre dans le capital de GoLiver Therapeutics, spin-off nantaise pionni\u00e8re de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative du foie - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/04\/GoLiver-T.png\",\"datePublished\":\"2019-04-30T08:47:42+00:00\",\"dateModified\":\"2019-04-30T10:34:32+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e\"},\"description\":\"Ce premier investissement de la SATT dans le capital d\u2019une start-up des Pays de la Loire confirme son soutien financier \u00e0 une biotech prometteuse.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/04\/GoLiver-T.png\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/04\/GoLiver-T.png\",\"width\":625,\"height\":357},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La SATT Ouest Valorisation entre dans le capital de GoLiver Therapeutics, spin-off nantaise pionni\u00e8re de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative du foie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e\",\"name\":\"Anne Guedon\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/anne\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La SATT Ouest Valorisation entre dans le capital de GoLiver Therapeutics, spin-off nantaise pionni\u00e8re de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative du foie - R\u00e9seau SATT","description":"Ce premier investissement de la SATT dans le capital d\u2019une start-up des Pays de la Loire confirme son soutien financier \u00e0 une biotech prometteuse.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/","twitter_misc":{"Written by":"Anne Guedon","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/"},"author":{"name":"Anne Guedon","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e"},"headline":"La SATT Ouest Valorisation entre dans le capital de GoLiver Therapeutics, spin-off nantaise pionni\u00e8re de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative du foie","datePublished":"2019-04-30T08:47:42+00:00","dateModified":"2019-04-30T10:34:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/"},"wordCount":499,"image":{"@id":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/04\/GoLiver-T.png","articleSection":["News","SATT Network"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/","url":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/","name":"La SATT Ouest Valorisation entre dans le capital de GoLiver Therapeutics, spin-off nantaise pionni\u00e8re de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative du foie - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/04\/GoLiver-T.png","datePublished":"2019-04-30T08:47:42+00:00","dateModified":"2019-04-30T10:34:32+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e"},"description":"Ce premier investissement de la SATT dans le capital d\u2019une start-up des Pays de la Loire confirme son soutien financier \u00e0 une biotech prometteuse.","breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/04\/GoLiver-T.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/04\/GoLiver-T.png","width":625,"height":357},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/la-satt-entre-dans-le-capital-de-goliver-therapeutics-spin-off-nantaise-pionniere-de-la-medecine-regenerative-du-foie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"La SATT Ouest Valorisation entre dans le capital de GoLiver Therapeutics, spin-off nantaise pionni\u00e8re de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative du foie"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e","name":"Anne Guedon","url":"https:\/\/www.satt.fr\/en\/author\/anne\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/14354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=14354"}],"version-history":[{"count":1,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/14354\/revisions"}],"predecessor-version":[{"id":14356,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/14354\/revisions\/14356"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/14351"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=14354"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=14354"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=14354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}